Neogen to Announce Q1 Earnings on April 9th
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 1 hour ago
0mins
Should l Buy NEOG?
Source: seekingalpha
- Earnings Announcement Date: Neogen (NEOG) is set to announce its Q1 earnings on April 9th before market open, with a consensus EPS estimate of $0.05, reflecting a 25% year-over-year improvement in profitability.
- Revenue Expectations: Despite the optimistic EPS outlook, the revenue estimate stands at $204.62 million, indicating a 2.2% year-over-year decline, which raises concerns about the company's sales growth and could impact investor confidence.
- Historical Performance Review: Over the past two years, Neogen has exceeded EPS estimates 50% of the time and revenue estimates 88% of the time, demonstrating a degree of stability and reliability in its financial performance.
- Expectation Revision Dynamics: In the last three months, there have been no upward revisions to EPS estimates and two downward revisions, while revenue estimates saw four upward revisions, reflecting differing market perceptions of the company's future growth potential, which may influence stock price volatility.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy NEOG?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on NEOG
Wall Street analysts forecast NEOG stock price to fall
4 Analyst Rating
2 Buy
2 Hold
0 Sell
Moderate Buy
Current: 9.980
Low
6.50
Averages
8.17
High
10.00
Current: 9.980
Low
6.50
Averages
8.17
High
10.00
About NEOG
Neogen Corporation and subsidiaries are engaged in developing, manufacturing and marketing a diverse line of products and services dedicated to food and animal safety. The Company has developed comprehensive solutions spanning the Food Safety, Livestock, and Pet Health & Wellness markets. Its segments include Food Safety and Animal Safety. The Food Safety segment is primarily engaged in the development, production and marketing of diagnostic test kits and related products used by food producers and processors to detect harmful natural toxins, foodborne bacteria, allergens and levels of general sanitation. The Animal Safety segment is primarily engaged in the development, production and marketing of products dedicated to animal safety, including a complete line of consumable products marketed to veterinarians and animal health product distributors. This segment also provides genomic identification and related interpretive bioinformatic services.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Neogen to Announce Q1 Earnings on April 9th
- Earnings Announcement Date: Neogen (NEOG) is set to announce its Q1 earnings on April 9th before market open, with a consensus EPS estimate of $0.05, reflecting a 25% year-over-year improvement in profitability.
- Revenue Expectations: Despite the optimistic EPS outlook, the revenue estimate stands at $204.62 million, indicating a 2.2% year-over-year decline, which raises concerns about the company's sales growth and could impact investor confidence.
- Historical Performance Review: Over the past two years, Neogen has exceeded EPS estimates 50% of the time and revenue estimates 88% of the time, demonstrating a degree of stability and reliability in its financial performance.
- Expectation Revision Dynamics: In the last three months, there have been no upward revisions to EPS estimates and two downward revisions, while revenue estimates saw four upward revisions, reflecting differing market perceptions of the company's future growth potential, which may influence stock price volatility.
See More
Neogen Corporation to Release Q3 Earnings on April 9
- Earnings Release Announcement: Neogen Corporation is set to release its Q3 earnings on April 9, with analysts projecting earnings of 5 cents per share, a 50% decrease from 10 cents last year, indicating profitability challenges for the company.
- Market Reaction: Despite the declining earnings forecast, Neogen's stock rose by 1.6% on Monday, reflecting cautious optimism among investors regarding the company's future performance, possibly linked to confidence in its long-term growth potential.
- Analyst Expectations: The downward revision of earnings expectations by analysts may stem from increased industry competition and changing market demand, highlighting the challenges Neogen faces in maintaining profitability and the need for effective strategies to navigate market fluctuations.
- Future Outlook: As the earnings release approaches, investors will closely monitor Neogen's performance and management's future guidance to assess the company's adaptability and growth potential in the current economic environment.
See More
Neogen Corp Sees Surge in Options Trading Volume
- Surge in Options Volume: Neogen Corp (Ticker: NEOG) experienced an options trading volume of 12,979 contracts today, equivalent to approximately 1.3 million shares, which represents about 55.7% of its average daily trading volume of 2.3 million shares over the past month, indicating a significant increase in market interest.
- High Demand for Call Options: Among the trades, the $12.50 strike call option stands out with 12,801 contracts traded today, representing around 1.3 million underlying shares of NEOG, suggesting strong investor expectations for future price appreciation.
- Block Inc Options Activity: Concurrently, Block Inc (Ticker: XYZ) saw an options trading volume of 37,408 contracts today, translating to approximately 3.7 million shares, which accounts for about 51.9% of its average daily trading volume of 7.2 million shares over the past month, reflecting robust trading activity.
- XYZ Call Options Surge: Notably, the $61 strike call option for XYZ recorded a trading volume of 4,622 contracts today, representing about 462,200 underlying shares, highlighting sustained bullish sentiment in the market for this stock.
See More
Neogen to Release Q3 Earnings on April 9, 2026
- Earnings Release Schedule: Neogen® Corporation will issue its third-quarter earnings report before the market opens on April 9, 2026, showcasing the latest financial and business performance updates, which are expected to provide investors with critical performance metrics and future outlook.
- Conference Call Details: Executives will host a webcast and conference call at 8:00 a.m. Eastern Time on the same morning, with investors able to join by dialing the toll-free number 888-660-6264 for North America or 646-517-3975 internationally, using Conference ID 70064#, ensuring timely access to key information for investors.
- Replay Access: A replay of the conference call and webcast will be available shortly after the conclusion of the call, accessible by dialing 877-674-7070 (North America) or 416-764-8692 (International) with the same passcode 70064#, providing convenience for investors who could not participate live.
- Company Mission and Vision: Neogen is committed to advancing global food security and animal well-being through scientific and technological advancements, having established a strong network of scientists and technical experts in over 140 countries, aiming to deliver optimized products and technology to reinforce its market leadership.
See More
Neogen Corp Shares Enter Oversold Territory
- Oversold Signal: Neogen Corp (Ticker: NEOG) saw its RSI drop to 28.7 during Monday's trading, indicating the stock has entered oversold territory, suggesting that recent heavy selling may be exhausting, prompting investors to look for buying opportunities.
- Price Fluctuation: NEOG shares hit a low of $9.145, with the current trading price at $9.43, fluctuating between a 52-week low of $3.8701 and a high of $11.425, reflecting changing market sentiment towards the stock.
- Market Comparison: Compared to the S&P 500 ETF (SPY) with an RSI of 36.7, NEOG's 28.7 RSI indicates relative weakness, potentially attracting investors looking for a rebound.
- Investor Sentiment: Despite the current price slump, the oversold signal may lead investors to reassess NEOG's value, especially after significant price declines, which could create buying opportunities.
See More
Zoetis Stock Falls 1.4% Following $160 Million Acquisition of Neogen's Animal Genomics Division
- Stock Performance: ZOETIS shares have decreased by 1.4% following a recent deal announcement.
- Acquisition Details: The company is set to acquire Neogen's animal genomics unit for a total of $160 million.
See More
Neogen to Announce Q1 Earnings on April 9th
- Earnings Announcement Date: Neogen (NEOG) is set to announce its Q1 earnings on April 9th before market open, with a consensus EPS estimate of $0.05, reflecting a 25% year-over-year improvement in profitability.
- Revenue Expectations: Despite the optimistic EPS outlook, the revenue estimate stands at $204.62 million, indicating a 2.2% year-over-year decline, which raises concerns about the company's sales growth and could impact investor confidence.
- Historical Performance Review: Over the past two years, Neogen has exceeded EPS estimates 50% of the time and revenue estimates 88% of the time, demonstrating a degree of stability and reliability in its financial performance.
- Expectation Revision Dynamics: In the last three months, there have been no upward revisions to EPS estimates and two downward revisions, while revenue estimates saw four upward revisions, reflecting differing market perceptions of the company's future growth potential, which may influence stock price volatility.
See More
Neogen Corporation to Release Q3 Earnings on April 9
- Earnings Release Announcement: Neogen Corporation is set to release its Q3 earnings on April 9, with analysts projecting earnings of 5 cents per share, a 50% decrease from 10 cents last year, indicating profitability challenges for the company.
- Market Reaction: Despite the declining earnings forecast, Neogen's stock rose by 1.6% on Monday, reflecting cautious optimism among investors regarding the company's future performance, possibly linked to confidence in its long-term growth potential.
- Analyst Expectations: The downward revision of earnings expectations by analysts may stem from increased industry competition and changing market demand, highlighting the challenges Neogen faces in maintaining profitability and the need for effective strategies to navigate market fluctuations.
- Future Outlook: As the earnings release approaches, investors will closely monitor Neogen's performance and management's future guidance to assess the company's adaptability and growth potential in the current economic environment.
See More
Neogen Corp Sees Surge in Options Trading Volume
- Surge in Options Volume: Neogen Corp (Ticker: NEOG) experienced an options trading volume of 12,979 contracts today, equivalent to approximately 1.3 million shares, which represents about 55.7% of its average daily trading volume of 2.3 million shares over the past month, indicating a significant increase in market interest.
- High Demand for Call Options: Among the trades, the $12.50 strike call option stands out with 12,801 contracts traded today, representing around 1.3 million underlying shares of NEOG, suggesting strong investor expectations for future price appreciation.
- Block Inc Options Activity: Concurrently, Block Inc (Ticker: XYZ) saw an options trading volume of 37,408 contracts today, translating to approximately 3.7 million shares, which accounts for about 51.9% of its average daily trading volume of 7.2 million shares over the past month, reflecting robust trading activity.
- XYZ Call Options Surge: Notably, the $61 strike call option for XYZ recorded a trading volume of 4,622 contracts today, representing about 462,200 underlying shares, highlighting sustained bullish sentiment in the market for this stock.
See More
Neogen to Release Q3 Earnings on April 9, 2026
- Earnings Release Schedule: Neogen® Corporation will issue its third-quarter earnings report before the market opens on April 9, 2026, showcasing the latest financial and business performance updates, which are expected to provide investors with critical performance metrics and future outlook.
- Conference Call Details: Executives will host a webcast and conference call at 8:00 a.m. Eastern Time on the same morning, with investors able to join by dialing the toll-free number 888-660-6264 for North America or 646-517-3975 internationally, using Conference ID 70064#, ensuring timely access to key information for investors.
- Replay Access: A replay of the conference call and webcast will be available shortly after the conclusion of the call, accessible by dialing 877-674-7070 (North America) or 416-764-8692 (International) with the same passcode 70064#, providing convenience for investors who could not participate live.
- Company Mission and Vision: Neogen is committed to advancing global food security and animal well-being through scientific and technological advancements, having established a strong network of scientists and technical experts in over 140 countries, aiming to deliver optimized products and technology to reinforce its market leadership.
See More
Neogen Corp Shares Enter Oversold Territory
- Oversold Signal: Neogen Corp (Ticker: NEOG) saw its RSI drop to 28.7 during Monday's trading, indicating the stock has entered oversold territory, suggesting that recent heavy selling may be exhausting, prompting investors to look for buying opportunities.
- Price Fluctuation: NEOG shares hit a low of $9.145, with the current trading price at $9.43, fluctuating between a 52-week low of $3.8701 and a high of $11.425, reflecting changing market sentiment towards the stock.
- Market Comparison: Compared to the S&P 500 ETF (SPY) with an RSI of 36.7, NEOG's 28.7 RSI indicates relative weakness, potentially attracting investors looking for a rebound.
- Investor Sentiment: Despite the current price slump, the oversold signal may lead investors to reassess NEOG's value, especially after significant price declines, which could create buying opportunities.
See More
Zoetis Stock Falls 1.4% Following $160 Million Acquisition of Neogen's Animal Genomics Division
- Stock Performance: ZOETIS shares have decreased by 1.4% following a recent deal announcement.
- Acquisition Details: The company is set to acquire Neogen's animal genomics unit for a total of $160 million.
See More
